Cargando…

Prescribing Patterns for Long-Acting Inhaled Bronchodilators Among Rural Adults With Chronic Obstructive Pulmonary Disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is prevalent in rural areas of the USA. Long-acting inhaled bronchodilators (LABDs) are a key tool in COPD management and are underutilized. The purpose of this study was to determine whether rates of prescriptions for LABD differed by payer a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunner, Wendy M., Siddiqui, Nadir, Scribani, Melissa B., Krupa, Nicole L., Riesenfeld, Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534191/ https://www.ncbi.nlm.nih.gov/pubmed/36258837 http://dx.doi.org/10.14740/jocmr4786

Ejemplares similares

Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population
por: Tsai, Ming-Jun, et al.
Publicado: (2015)

Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease
por: Wang, Meng-Ting, et al.
Publicado: (2019)

Evaluation of a Peer Led Chronic Pain Self-Management Program in a Rural Population
por: Pullyblank, Kristin, et al.
Publicado: (2022)

Trends in telehealth use among a cohort of rural patients during the COVID-19 pandemic
por: Pullyblank, Kristin, et al.
Publicado: (2023)

Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population: Erratum
Publicado: (2016)

Recruitment and engagement in disease self-management programs: Special concerns for rural residents reporting depression and/or anxiety
por: Pullyblank, Kristin, et al.
Publicado: (2022)

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
por: Donohue, James F, et al.
Publicado: (2011)

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
por: Asche, Carl Victor, et al.
Publicado: (2012)

Risk of Pneumonia with Inhaled Corticosteroid versus Long-Acting Bronchodilator Regimens in Chronic Obstructive Pulmonary Disease: A New-User Cohort Study
por: DiSantostefano, Rachael L., et al.
Publicado: (2014)

The paradoxical response to short-acting bronchodilator administration in patients with chronic obstructive pulmonary disease
por: Shin, Hong-Joon, et al.
Publicado: (2021)

The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease
por: Kliber, Agnes, et al.
Publicado: (2010)

Cardiovascular morbidity and the use of inhaled bronchodilators
por: Macie, Christine, et al.
Publicado: (2008)

Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilators
por: Hendrickx, Ramon, et al.
Publicado: (2017)

Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease
por: Fujimoto, Keisaku, et al.
Publicado: (2011)

Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study
por: Chen, Yen-Fu, et al.
Publicado: (2019)

Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2013)

A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD
por: Jara, Michele, et al.
Publicado: (2012)

Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
por: Bishwakarma, Raju, et al.
Publicado: (2017)

Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
por: Halpin, David M. G., et al.
Publicado: (2016)

Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator
por: Schou, Magnus, et al.
Publicado: (2019)

The role of inhaled and/or nasal corticosteroids on the bronchodilator response
por: Lee, Ju Kyung, et al.
Publicado: (2010)

Inhaled Bronchodilator Use for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L, et al.
Publicado: (2014)

Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy
por: Bengtson, Lindsay G.S., et al.
Publicado: (2018)

Short-acting bronchodilators for the management of acute exacerbations of chronic obstructive pulmonary disease in the hospital setting: systematic review
por: Kopsaftis, Zoe A., et al.
Publicado: (2018)

Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease
por: Roberts, Melissa H., et al.
Publicado: (2019)

Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in Chronic Obstructive Pulmonary Disease? Results from Post Hoc Subgroup Analyses
por: Iqbal, Ahmar, et al.
Publicado: (2015)

Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2013)

The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease
por: Beeh, Kai M.
Publicado: (2016)

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
por: Kozma, Chris M, et al.
Publicado: (2011)

Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study
por: Wurst, Keele E, et al.
Publicado: (2014)

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG results among healthcare workers in a rural upstate New York hospital system
por: Brunner, Wendy M., et al.
Publicado: (2020)

Frequency of satisfaction and dissatisfaction with practice among rural-based, group-employed physicians and non-physician practitioners
por: Waddimba, Anthony C., et al.
Publicado: (2016)

Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease
por: van der Vaart, Hester, et al.
Publicado: (2011)

Vitamin D and responses to inhaled fluticasone in severe chronic obstructive pulmonary disease
por: Kunisaki, Ken M, et al.
Publicado: (2011)

Bone marrow biopsy and aspiration: a departmental financial comparison in a rural hospital
por: Bethuel, Nancy W., et al.
Publicado: (2021)

Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease
por: Leaker, Brian R., et al.
Publicado: (2019)

Bronchodilator delivery with metered-dose inhaler during mechanical ventilation
por: Georgopoulos, Dimitris, et al.
Publicado: (2000)

Inhaled bronchodilator exposure in the management of bronchopulmonary dysplasia in hospitalized infants
por: Euteneuer, Joshua C., et al.
Publicado: (2020)

Prescribing patterns of nebulized bronchodilators: A prospective chart review
por: Yaxley, Julian P.
Publicado: (2016)

Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
por: Ramadan, Wijdan H, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v2ftcvn3pq5kh1ft4jil59nhm4